Mein Warenkorb

Biotinylated Human Claudin-6 / CLDN6 Full Length Protein (VLP)

User Reviews
Product Number/Spec
Price
Menge
CL6-H82P3-20ug
$620.00
CL6-H82P3-100ug
$1235.00
CL6-H82P3-500ug (250ug X 2)
$4305.00
ETA of in-stock products:2 business days
Gesamtanzahl Product Amount$ 0

Product Details

  • Application

    1. Immunization
    2. Cell based assay (FACS or functional assay)
    3. Screening (ELISA)
  • Synonyms

    Claudin-6, CLDN6

  • Source

    Biotinylated Human Claudin-6 Full Length Protein (VLP) (CL6-H82P3) is expressed from human 293 cells (HEK293). It contains AA Met 1 - Val 220 (Accession # P56747).

    Predicted N-terminus: Met 1

  • Molecular Characterization

    *The isotype control of empty/mock VLP (Cat. No. VLP-N82P3) is sold separately and not included in protein, you can follow the link for product information.

    1. Structure

      Virus-like particles (VLPs) are protein particles that mimic the shape of viruses but lack a viral genome, and incorporating transmembrane proteins on the external surface.

    2. Synthesis Process

      Envelope virus-like particles (eVLPs) are produced by co-expressing target membrane proteins with viral structural proteins in mammalian cells, enabling native embedding of membrane proteins into the lipid bilayer during VLP budding. This approach preserves authentic conformation, post-translational modifications, and orientation, while creating a completely detergent-free environment with repetitive multivalent display and strong immunogenicity making them ideal for immunization, binding assays in antibody discovery and screening (ELISA), and cell-based assays such as FACS, etc.

  • Labeling

    The VLP is biotinylated with propriety technology.

  • Protein Ratio

    Passed as determined by the HABA assay / binding ELISA.

  • Formulation

    The VLPs are highly immunogenic, so the immunization strategy should be optimized (antigen dose, regimen and adjuvant).

    Supplied as 0.2 μm filtered solution in PBS, Arginine, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Shipping

    This product is supplied and shipped with dry ice, please inquire the shipping cost.

  • Storage

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. The product MUST be stored at -70°C or lower upon receipt;
    2. -70°C for 12 months under sterile conditions.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Kunden haben auch angesehen

Data Display

  • Bioactivity-ELISA

     Claudin-6 ELISA

    Immobilized Biotinylated Human Claudin-6 Full Length Protein (VLP) (Cat. No. CL6-H82P3) at 1 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Anti-Human Claudin-6 antibody, Human IgG1 with a linear range of 0.05-2 ng/mL (QC tested).

    Protocol
  •  Claudin-6 ELISA

    ELISA comparison of biotinylated full-length human Claudin-6 (virus-like particles) using anti-Claudin-6 antibody shows ACRO (Cat. No. CL6-H82P3) has superior bioactivity to Company K (Routinely tested).

    Protocol
  • Bioactivity-SPR

     Claudin-6 SPR

    Biotinylated Human Claudin-6 Full Length Protein (VLP) (Cat. No. CL6-H82P3) immobilized on SA Chip can bind Anti-Claudin-6 Antibody, Human IgG1 with an affinity constant of 0.283 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

    Protocol
  • Identity-DLS

     Claudin-6 DLS

    The mean peak Radius of VLP is 70-90 nm with more than 95% intensity as determined by dynamic light scattering (DLS).

User Reviews
Publish Comment

Background Introduction

An oncofetal tight junction protein absent in normal adult tissues but aberrantly expressed in ovarian, endometrial, and testicular cancers. Its strict cancer specificity and extracellular accessibility make it an ideal candidate for CAR-T cell therapy and bispecific antibody development.

Frontier Progress

 
Drug Development Progress
  • English Name:

    Claudin 6

  • Category:

  • Listed Drugs Count:

    0 Details

  • Clinical Drugs Count:

    15 Details

  • Highest R&D Stage:

    Phase 2 Clinical

Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Kunden haben auch angesehen
  • Data Display
  • User Reviews
  • Hintergrund
Kontaktieren Sie uns